MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced the publication of preclinical data for its lead cell therapy program using the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback